The Viral Clearance market is a subset of the biotechnology industry that focuses on the development of technologies and processes to reduce the presence of viruses in biopharmaceutical products. This is done through the use of viral clearance strategies such as filtration, chromatography, and inactivation. These strategies are used to reduce the risk of contamination and ensure the safety of biopharmaceutical products. Viral clearance is an important part of the biopharmaceutical manufacturing process, as it helps to ensure the safety and efficacy of the products. It is also used to reduce the risk of cross-contamination between batches of biopharmaceuticals. Some companies in the Viral Clearance market include Merck, Sartorius, Pall Corporation, and Thermo Fisher Scientific. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
